bicalutamide bluefish 50 mg
bluefish pharmaceuticals ab - bikalutamid - tablett, filmdrasjert - 50 mg
duloxetine aristo 60 mg
aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 60 mg
duloxetine aristo 30 mg
aristo pharma gmbh - duloksetinhydroklorid - enterokapsel, hard - 30 mg
stromolol 2.5 mg
aristo pharma gmbh - bisoprololfumarat - tablett, filmdrasjert - 2.5 mg
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
bactrim 40 mg/ ml / 8 mg/ ml
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - mikstur, suspensjon - 40 mg/ ml / 8 mg/ ml
bactrim 400 mg / 80 mg
eumedica pharmaceuticals gmbh - sulfametoksazol / trimetoprim - tablett - 400 mg / 80 mg
naltrexone poa pharma 50 mg
poa pharma scandinavia ab - naltreksonhydroklorid - tablett, filmdrasjert - 50 mg
zoledronic acid oresund pharma 4 mg/100 ml
oresund pharma aps - zoledronsyremonohydrat - infusjonsvæske, oppløsning - 4 mg/100 ml
metadon pharmadone 100 mg
unimedic pharma ab - metadonhydroklorid - mikstur, oppløsning med bringebærsmak - 100 mg